25
April2024
Vitarka
ANTYA’s views on investing markets, economy, and more
Latest Insights
First Republic Bank : Murphy’s Law in Action – Effectively Insolvent
First Republic Bank (“FRC”, or the “Bank), with a current market capitalization of $4.2B, is still standing with conflicting opinions as to its viability. Although The Federal Reserve (“The Fed”),…
Well Health Technologies Corp. : It is a Bird, It is a Plane, Noooo! It is a Torpedo. It will Blow-Up.
Download this Report “ This is why, aspirationally speaking, we like to refer to ourselves as the Berkshire Hathaway of tech-enabled healthcare.” Q4-2020 “ …capital allocation decisions are centralized and thoughtfully planned to ensure that the company is always making the most compelling and accretive investment decisions.” Q3-2020 “ It …
Bristol Myers Squib & Celgene–Starboard Objections Addressed Today- Successful Deal Closure Probable
Bristol Myers Squibb Co (BMY US) (“Bristol-Myers”, “BMY” or the “Company”) has been the subject of multiple stories in the media regarding its fate as a standalone entity, since announcing its intent to acquire Celgene Corp (CELG US) (“Celgene”) in the first week of 2019. Many investors have expressed scepticism …
Facebook Inc. – Is Consensus Overly Cautious?
Facebook Inc A (FB US) (“FB” or the “Company”) has faced multiple regulatory challenges and intense scrutiny of its platform in 2017 and in 2018. The Company increased its spending on security, hired employees for news and post-verifications, accelerated investments in artificial intelligence to police its platform and significantly increased …
Meituan Dianping – Is a One Billion U.S. Dollar Impairment Forthcoming?
In the frenzy surrounding China’s technology sector in 2017 and 2018, it is rumoured that a unicorn was created every week. For the uninitiated, in tech parlance a unicorn means a private company funded by a venture capitalist that is currently valued at US$1 billion. The realists amongst us know …
Tesla Motors – Gaining Industrial Strength
To the extent Q4-18 results from Tesla Motors (TSLA US) (“Tesla” or the “Company”) were expected to strengthen the hands of naysayers and bearish investors, the results were disappointing. Others that believe in Musk’s mission of getting rid of fossil fuels and freeing up valuable time from the chore of …
Bristol Myers Squib – Reaffirming Its View on Celgene Corp
Bristol-Myers Squib (“BMS” or the “company”) provided additional commentary on its acquisition of Celgene Corp (“Celgene”) which we discussed in Celgene and Bristol-Myers Squibb – Undervalued and Underappreciated . While the management of BMS maintained its positive stance, investors and analysts that participated in the quarterly conference call appeared skeptical …
Celgene and Bristol-Myers Squibb – Undervalued and Underappreciated
Happy New Year to all our readers. We took a break from writing in December and early January to recharge and are now back in earnest. There is a lot to write about and opine on, especially given that our inaugural year on the platform in 2018 proved especially fertile …
Tesla Motors Inc: Come Hell or High Water
Tesla Motors (TSLA US) (“Tesla” or the “Company”) was amongst the most reviled, the most shorted, and one of the most volatile stocks of 2018. Bearish investors, co-opted columnists, business television anchors that thrive on attention deficit disorder, both their own and that of the gullible viewership coalesced around a …
Tencent Music Entertainment Group – Back in the Groove with an Unjustified Valuation Multiple
Tencent Music Entertainment (TME US) (“TME” or the “Company”) did not waste a single moment, by re-entering the equity issuance fray, as soon as President Trump and Comrade Xi announced a much-appreciated but little anticipated truce at the end of the G-20 summit over the weekend in Argentina. The very …
Tesla Motors Inc. — For Whom the Bell Tolls
In ANTYA’s view, Tesla Motors (TSLA US) (“Tesla” or the “Company”) is winning the war of attrition brought upon it by self-inflicted wounds courtesy its top management, and, fictional attacks undertaken via malicious stories in the news media by those bearish on the Company’s business prospects and therefore Tesla’s equity …
Meituan Dianping – Is the Impressive Growth Sustainable?
Meituan Dianping (3690 HK) (“MD” or the “Company”) reported third-quarter results that were impressive by any yardstick. Consolidated revenues jumped 97.2% YoY to RMB 19.07 billion, while gross profit increased by 33.2% to RMB 4.5 billion. All three segments of the Company viz. food delivery, hotel bookings & media, and …